SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) March 1, 2004
IMPAC Medical Systems, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 000-50082 | 94-3109238 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 100 West Evelyn Avenue, Mountain View, CA | 94041 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code (650) 623-8800
(Former name or former address if changed since last report)
Item 5.Other Events and Required FD Disclosure.
On March 1, 2004, IMPAC Medical Systems, Inc. issued a press release announcing that it intends to restate its financial statements and receipt of a Nasdaq delisting notification. A copy of the press release is attached as Exhibit 99.1.
Item 12.Results of Operations and Financial Condition.
On March 1, 2004, IMPAC Medical Systems, Inc. issued a press release announcing that it intends to restate its financial statements and receipt of a Nasdaq delisting notification. A copy of the press release is attached as Exhibit 99.1.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
IMPAC MEDICAL SYSTEMS, INC. | ||
By: | /s/ KENDRA A. BORREGO | |
Kendra A. Borrego | ||
Chief Financial Officer | ||
Date: March 1, 2004
3
EXHIBIT INDEX
| Exhibit No. | Description | |
| 99.1 | IMPAC Medical Systems, Inc. Press Release dated March 1, 2004. |
4